t: 949-720-5796, e: email@example.com
Matt Dolan is a Senior Research Analyst focusing on Medical Technology: Devices & Diagnostics. Mr. Dolan has followed the industry for nearly a decade and has been the senior analyst at ROTH for about six years. His investment views have been cited in Barrons, Investors Business Daily, Wall Street Transcript, Forbes and BusinessWeek, as well as Bloomberg, Associated Press and Dow Jones publications, and he has spoken as an industry expert on Capitol Hill. Prior to joining ROTH Capital Partners, Mr. Dolan formed a trading group at the Chicago Board of Trade and Chicago Board Options Exchange and also worked as an analyst with a hedge fund in New York, specializing in small-cap medical device, biotechnology, and pharmaceutical companies. Mr. Dolan received his Bachelor's degree in Economics/Pre-Med from Northwestern University.